Pieris Pharmaceuticals Stock Quote PIRS - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

10.2976

Bid

10.06

Ask

10.39

Volume

5,138

10.25 Day's Range 10.44

9.31 52 Week Range 80.80

Market Cap

1.018B

Previous Close

10.20

Open

10.25

Last Trade

10.22

Last Trade Time

Financial Volume

$ 52,983

VWAP

10.312

Average Volume (3m)

530,454

Shares Outstanding

98,851,927

Dividend Yield

PE Ratio

-41.48

Earnings Per Share (EPS)

-0.25

Revenue

42.81M

Net Profit

-24.54M

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of mol... Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343, and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States. Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.pieris.com

Headquarters

Las Vegas, Nevada, USA

Founded

1970

Pieris Pharmaceuticals Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker PIRS. The last closing price for Pieris Pharmaceuticals was $10.20. Over the last year, Pieris Pharmaceuticals shares have traded in a share price range of $ 9.31 to $ 80.80.

Pieris Pharmaceuticals currently has 98,851,927 shares outstanding. The market capitalization of Pieris Pharmaceuticals is $1.02 billion. Pieris Pharmaceuticals has a price to earnings ratio (PE ratio) of -41.48.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0624	-0.602316602317	10.36	10.6	9.31	6426	9.83304866	CS
4	-0.6924	-6.30027297543	10.99	11.54	9.31	6140	10.72742318	CS
12	-2.9024	-21.9878787879	13.2	22.32	9.31	530454	15.00964312	CS
26	-4.3664	-29.7763229678	14.664	22.32	9.31	507353	14.24499783	CS
52	-60.9024	-85.5370786517	71.2	80.8	9.31	1298283	20.18910802	CS
156	-253.7024	-96.0993939394	264	492	9.31	1019572	161.86388242	CS
260	-329.7024	-96.9712941176	340	496	9.31	1211760	222.5055313	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLGOMicroAlgo Inc	$ 11.98 (667.95%)	185.79M
VSTEVast Renewable Ltd	$ 4.49 (79.60%)	9.96M
SOBRSOBR Safe Inc	$ 0.4507 (71.04%)	268.05M
MFImF International Ltd	$ 1.315 (41.40%)	2.02M
DHACUDigital Health Acquisition Corporation	$ 23.06 (40.61%)	3.95k
JDZGJIADE Ltd	$ 1.72 (-86.21%)	14.66M
NDRAENDRA Life Sciences Inc	$ 0.086 (-60.37%)	72.34M
ALBTAvalon GloboCare Corporation	$ 0.85 (-30.89%)	5.97M
EQEquillium Inc	$ 1.05 (-28.57%)	10.83M
ATGLAlpha Technology Group Limited	$ 2.86 (-28.32%)	103.33k
SOBRSOBR Safe Inc	$ 0.4507 (71.04%)	268.05M
MLGOMicroAlgo Inc	$ 11.98 (667.95%)	185.79M
SQQQProShares UltraPro Short QQQ	$ 9.86 (-0.70%)	125.61M
FFIEFaraday Future Intelligent Electric Inc	$ 0.557 (-10.85%)	101.59M
CRKNCrown Electrokinetics Corporation	$ 0.1044 (-11.45%)	92.21M